QR Pharma Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:QR Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7604
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
QR Pharma Inc (QR Pharma) is a pharmaceutical company that develops novel drugs for the treatment of alzheimer’s disease, parkinson’s disease and neurodegenerative disorders. The company’s product candidate includes posiphen, which inhibits the translation of amyloid precursor protein. Its Posiphen inhibits synthesis of amyloid precursor protein (APP), Tau and a-Synuclein. QR Pharma also develops drugs for huntington’s disease, down syndrome, traumatic brain injury and post operative cognitive decline. The company works in partnership with laboratories for technical support to further its pipeline. QR Pharma is headquartered in Chester, Pennsylvania, the US.

QR Pharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
QR Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QR Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
QR Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QR Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
QR Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
QR Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
QR Pharma Raises USD0.3 Million in Venture Financing 10
QR Pharma Raises USD0.8 Million in Series A Venture Financing 11
QR Pharma Raises USD1.1 Million in Series A Preferred Stock Financing 12
QR Pharma Raises US$0.45 Million In Venture Financing 13
QR Pharma Raises US$0.11 Million In Venture Financing 14
Partnerships 15
QR Pharma Enters into Research Agreement with Rockefeller University 15
QR Pharma Inc – Key Competitors 16
QR Pharma Inc – Key Employees 17
QR Pharma Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Jan 24, 2017: QR Pharma Announces New Scientific Advisory Board with Appointment of World-Class Neurodegenerative Disease Experts 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
QR Pharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
QR Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QR Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
QR Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QR Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
QR Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
QR Pharma Raises USD0.3 Million in Venture Financing 10
QR Pharma Raises USD0.8 Million in Series A Venture Financing 11
QR Pharma Raises USD1.1 Million in Series A Preferred Stock Financing 12
QR Pharma Raises US$0.45 Million In Venture Financing 13
QR Pharma Raises US$0.11 Million In Venture Financing 14
QR Pharma Enters into Research Agreement with Rockefeller University 15
QR Pharma Inc, Key Competitors 16
QR Pharma Inc, Key Employees 17

List of Figures
QR Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
QR Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
QR Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
QR Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QR Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
QR Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QR Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[QR Pharma Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ReVision Optics Inc:医療機器:M&Aディール及び事業提携情報
    Summary ReVision Optics Inc (ROI), formerly IntraLens Vision Inc is a medical device company offers optical solutions. The company offers Raindrop near vision inlay that offers a long term solution to near vision loss caused by aging. It develops products made of water materials that are implanted i …
  • Isagenix International LLC:企業の戦略的SWOT分析
    Isagenix International LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Hansgrohe SE:企業の戦略・SWOT・財務情報
    Hansgrohe SE - Strategy, SWOT and Corporate Finance Report Summary Hansgrohe SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • University of Pennsylvania:企業のM&A・事業提携・投資動向
    University of Pennsylvania - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Pennsylvania Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • HubSpot, Inc.:企業のM&A・事業提携・投資動向
    HubSpot, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HubSpot, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Nielsen Holdings PLC:企業の戦略・SWOT・財務情報
    Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • First Republic Bank:企業のM&A・事業提携・投資動向
    First Republic Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First Republic Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Parkway Properties Inc:企業のM&A・事業提携・投資動向
    Parkway Properties Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Parkway Properties Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • SK Telecom Co., Ltd.:戦略・SWOT・企業財務分析
    SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Global Payments Inc.:企業の戦略・SWOT・財務情報
    Global Payments Inc. - Strategy, SWOT and Corporate Finance Report Summary Global Payments Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Psychemedics Corp (PMD):企業の財務・戦略的SWOT分析
    Summary Psychemedics Corp (Psychemedics) provides clinical laboratory services. The company provides testing for drugs abuse using hair analysis. It also offers drug panel, workplace drug testing, personal drug testing kits, school drug testing, alcohol testing, synthetic cannabinoids testing, benzo …
  • George Weston Ltd (WN):企業の財務・戦略的SWOT分析
    George Weston Ltd (WN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Midas Group Ltd:企業の戦略・SWOT・財務分析
    Midas Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Midas Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Companhia de Saneamento Basico do Estado de Sao Paulo (SBSP3):企業の財務・戦略的SWOT分析
    Summary Companhia de Saneamento Basico do Estado de Sao Paulo (SABESP) is an environmental consulting company that is responsible for supplying water and collecting and treating sewage in municipalities of Sao Paulo state. The company provides water and sewage services in another four municipalities …
  • ONEOK Partners LP (OKS)-石油・ガス分野:企業M&A・提携分析
    Summary ONEOK Partners, L.P. (ONEOK Partners), a subsidiary of Oneok, Inc., is a midstream energy company. The company carries out gathering, processing, and storage and transportation of natural gas. It operates through master limited partnerships. ONEK Partners owns natural gas liquids (NGL) syste …
  • NovoCure Ltd (NVCR):企業の財務・戦略的SWOT分析
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Abbott Laboratories (ABT):企業の財務・戦略的SWOT分析
    Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Synopsys Inc (SNPS):企業の財務・戦略的SWOT分析
    Synopsys Inc (SNPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • UCB S.A.:企業の戦略・SWOT・財務分析
    UCB S.A. - Strategy, SWOT and Corporate Finance Report Summary UCB S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • AorTech International Plc (AOR):医療機器:M&Aディール及び事業提携情報
    Summary AorTech International plc (AorTech) is an Intellectual Property (IP) holding company. It develops and commercializes biologically stable polymers for next generation medical devices. It provides a broad range of polyurethane technologies for applications in cardiovascular surgery, interventi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆